Clin2
NCT07400224Possibly a fitRecruiting

New PET imaging test for cancer, heart, or immune disease

Hyperthyroidism, AutoimmuneCardiovascular AbnormalitiesMalignant Tumor

Part of Cancer, Eyes & vision, Genetic & congenital, Heart & circulation, Hormones & metabolism, Immune system & allergy clinical trials.

This study tests a new type of PET scan using a special tracer called Al18F-NOTA-FAPI-04 to see if it can better detect cancer, heart disease, or immune system conditions. The goal is to find out how well this imaging method works for diagnosis or monitoring of these diseases.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
600 people
Ages
18 years to 88 years
Study type
Interventional

Who can take part

  • You must be 18 years old or older.
  • You must have had a health check-up in the last 3 months, including a chest X-ray or CT scan and an abdominal ultrasound, and no serious health problems were found.
  • You cannot have had frequent radiation exposure from CT or PET scans recently: no CT scan within the past 3 months and no PET/CT scan within the past month.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07878338Recruiting· Phase 2
PET imaging for nonischemic cardiomyopathy

This trial uses a special PET scan to look at heart tissue in people with nonischemic cardiomyopathy. The scan may help doctors better understand the condition and guide treatment.

Beijing
NCT07464132Recruiting· Phase 1/Phase 2
New PET scan for detecting certain diseases

This trial uses a special PET scan tracer to see if it can help find and monitor diseases linked to a protein called FAP. It is for both cancer patients needing a biopsy and healthy volunteers.

Beijing, Beijing Municipality
NCT07657494Recruiting
PET scan study for aggressive lymphoma patients

This study uses a special PET/CT scan to look at the environment around your lymphoma. The goal is to see if this scan can predict how well your treatment will work and your long-term outcome.

Beijing, Chao Yang
NCT07705074Not yet recruiting· Phase 1/Phase 2
FAPI pet scan for cancer and other diseases

This trial uses a special PET scan to look at diseases like cancer. It aims to see if this new imaging method can help doctors find or monitor disease better. This could be helpful for people with confirmed or suspected cancer or other conditions.

Baden, Canton of Aargau
NCT06916338Recruiting
PET imaging study using 18F-FAPI-04 for breast cancer

This study tests a new imaging agent (18F-FAPI-04) for PET scans to see if it can better detect breast cancer or its spread. It may help doctors find tumors more clearly.

Qingdao, Shandong
NCT07877324Recruiting
Imaging heart artery inflammation with a new tracer

This study uses a special PET/CT scan to look for inflammation in the artery walls of the heart. It will help doctors understand how inflammation relates to coronary artery disease and recent heart attacks.

Turku

Hear when a new Cardiovascular Abnormalities trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.